mavelertinib - Moligand™, ≥98% , Epidermal growth factor receptor erbB1 inhibitor, CAS No.1776112-90-3, Epidermal growth factor receptor erbB1 inhibitor
Disponible
SKU
M611747
Mavelertinib (PF-06747775) is an orally available, selective and potent EGFR tyrosine kinase (EGFR TKI) inhibitor with inhibitory effects on T790M/L858R and T790M/Del, and can be used in the study of oncology and respiratory diseases.
Más Información
| CAS | 1776112-90-3 |
|---|---|
| Sinónimos | GTPL9765 | PF6747775 | AC-33593 | (2S,3S)-2,3-bis(4-methylbenzoyloxy)succinic acid | MAVELERTINIB [INN] | YXX2180047 | JYIUNVOCEFIUIU-GHMZBOCLSA-N | PF-06747775 | PF-06747775, >=98% (HPLC) | Mavelertinib | UNII-YXX2180047 | EX-A4999 | 2-Propenamide, N-[(3 |
| Especificaciones y pureza | Moligand™, ≥98% |
| Condiciones de almacenamiento de almacenamiento | Store at -20°C |
| Enviado en | Ice chest + Ice pads |
| Product Description |
Mavelertinib (PF-06747775) is an orally available, selective and potent EGFR tyrosine kinase (EGFR TKI) inhibitor with inhibitory effects on T790M/L858R and T790M/Del, and can be used in the study of oncology and respiratory diseases.
|
| Pubchem Sid | 528768705 |
| Número CE | 815-270-2 |
| PubChem CID | 91668194 |
| Fórmula molecular | C18H22FN9O2 |
Reseñas
Reseñas de cliente
Remind me later